Literature DB >> 9124741

Effect of a growth hormone treatment on bone orthotropic elasticity in dwarf rats.

S S Kohles1, D A Martinez, J R Bowers, A C Vailas, R Vanderby.   

Abstract

A refinement of the current ultrasonic elasticity technique was used to measure the orthotropic elastic properties of rat cortical bone as well as to quantify changes in elastic properties, density, and porosity of the dwarf rat cortex after a treatment with recombinant human growth hormone (rhGH). The ultrasonic elasticity technique was refined via optimized signal management of high-frequency wave propagation through cubic cortical specimens. Twenty dwarf rats (37 days old) were randomly assigned to two groups (10 rats each). The dwarf rat model (5-10% of normal GH) was given subcutaneous injections of either rhGH or saline over a 14-day treatment period. Density was measured using Archimedes technique. Porosity and other microstructural characteristics were also explored via scanning electron microscopy and image analysis. Statistical tests verified significant decreases in cortical orthotropic Young's (-26.7%) and shear (-16.7%) moduli and density (-2.42%) concomitant with an increase in porosity (+125%) after rhGH treatments to the dwarf model (p < 0.05). A change in material symmetry from orthotropy toward planar isotropy within the radial-circumferential plane after GH treatments was also noted. These results demonstrate some alteration in bone properties at this time interval. Structural implications of these changes throughout physiological loading regimens should be explored.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; NASA Discipline Number 26-10; NASA Program Space Physiology and Countermeasures; Non-NASA Center

Mesh:

Substances:

Year:  1997        PMID: 9124741     DOI: 10.1007/bf02738540

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  1 in total

1.  Applications of an anisotropic parameter to cortical bone.

Authors:  S S Kohles
Journal:  J Mater Sci Mater Med       Date:  2000-04       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.